Study of Tirbanibulin 1% Ointment to Treat Hand Warts in Children and Teens Ages 8 to 18

What this Trial Is About

Warts on the hands are common, non-cancerous skin growths caused by the human papillomavirus HPV. Treating warts in children can be difficult because common treatments like cryotherapy and injections are often not well tolerated. Existing creams have limited success and require long use. Researchers are studying tirbanibulin ointment as a possible effective and better-tolerated treatment for hand warts in children aged 8 to 18 years. Participants will apply tirbanibulin ointment 1% to the affected areas on their hands themselves. This study is open-label and involves one treatment group using only this topical medication. Treatment cycles will last up to four cycles, with participants applying the ointment as directed during the study period. During the study, children will be monitored for wart clearance two months after finishing treatment cycles. Assessments will include wart count and size, overall health status, and any side effects. The study will last through treatment and follow-up, ensuring safety and measuring how well the ointment works to clear warts on the hands.

Tirbanibulin for Pediatric Warts